|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Sylvain Celanire , Sonia PoliPublisher: Springer International Publishing AG Imprint: Springer International Publishing AG Edition: Softcover reprint of the original 1st ed. 2015 Volume: 13 Dimensions: Width: 15.50cm , Height: 1.80cm , Length: 23.50cm Weight: 5.037kg ISBN: 9783319378947ISBN 10: 3319378945 Pages: 323 Publication Date: 23 August 2016 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: In Print ![]() This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsAntipsychotics and the Dopamine–Serotonin Connection.- GLYT1 Inhibitors: From Hits to Clinical Candidates.- Metabotropic Glutamate Receptor 2 Activators.- Activation of the mGlu5 Receptor for the Treatment of Schizophrenia and Cognitive-Deficit-Associated Disorders.- Muscarinic Acetylcholine Receptor Activators.- Nicotinic Acetylcholine Receptor Modulators.- The Use of PDE10A and PDE9 Inhibitors for Treating Schizophrenia.ReviewsFrom the book reviews: The target audience ... is primarily researchers in psychopharmacology involved in drug development. ... Each chapter concludes with citations of the pertinent scientific literature. This book covering small molecular therapeutics for schizophrenia would be a useful review for researchers studying this area. (Michael Joel Schrift, Doody's Book Reviews, March, 2015) From the book reviews: The target audience ... is primarily researchers in psychopharmacology involved in drug development. ... Each chapter concludes with citations of the pertinent scientific literature. This book covering small molecular therapeutics for schizophrenia would be a useful review for researchers studying this area. (Michael Joel Schrift, Doody's Book Reviews, March, 2015) Author InformationTab Content 6Author Website:Countries AvailableAll regions |